Combinational Treatments for Breast Cancer

Omid Tavallaei; Marzieh Marzbany; Mahsa Rasekhian

doi:10.4103/jrptps.JRPTPS_89_19

Outlines

Abstract
References
Copyright

https://doi.org/10.4103/jrptps.JRPTPS_89_19

Combinational Treatments for Breast Cancer

Author(s):

Omid Tavallaei¹,

Marzieh Marzbany¹,

Mahsa Rasekhian^1,*

1Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

Journal of Reports in Pharmaceutical Sciences:Vol. 9, issue 2; 279-87

Published online:Oct 07, 2020

Article type:Systematic Review

Received:Oct 05, 2019

Accepted:Apr 27, 2020

How to Cite:Omid TavallaeiMarzieh MarzbanyMahsa RasekhianCombinational Treatments for Breast Cancer.J Rep Pharm Sci.9(2):e147123.https://doi.org/10.4103/jrptps.JRPTPS_89_19.

Abstract

Heterogenicity is an indispensable element of breast cancer, which manifests itself on clinical, histopathological, and molecular levels. This heterogenicity could be a determinant factor of disease progression and drug resistance in the patients. Common therapies for metastatic breast cancer include surgery, radiotherapy, chemotherapy, and immunotherapy. On the introduction of biologic medicine, target therapy, and gene therapy, a potential has been reached to lower the rate of morbidity and mortality and also to improve the quality of life among patients with breast cancer. Although these treatments have been frequently proved by yielding promising results, a very few number of them have found their way into clinic settings due to progressive nature of these tumors, diversity of cancer populations and their microenvironments, genetic instability, and heterogenicity of breast cancers. As only minor advancements have been made in the case of recurrent metastatic breast cancer, handling this condition is now considered a medical necessity. According to genetic instability and heterogenicity of breast tumors, it is implausible to assume a single-targeted therapy could help treating most solid tumors. So, this review aimed to put together studies focused on combinational treatments targeting growth inhibition and apoptosis induction in breast cancer cells and comparing the results with monotherapies.

Keywords

breast cancer

combinational treatment

combinatorial treatment

References

1.
References are in the pdf file of the article.

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Omid Tavallaei:[PubMed][Scholar]
Marzieh Marzbany:[PubMed][Scholar]
Mahsa Rasekhian:[PubMed][Scholar]